The U.S. Food and Drug Administration (FDA) published a final guidance document entitled “Pediatric Information for X-ray Imaging Device Premarket Notifications,” encouraging manufacturers to consider child safety when designing X-ray imaging devices. In the guidance, which applies to new devices and modifications requiring the submission of a new 510(k), the FDA recommends manufacturers design these devices with protocols and instructions that address use on pediatric patients. It encourages the inclusion of pediatric indications and provides recommendations for labeling and instructions for use for X-ray imaging devices likely to be used on children.

December 19, 2017 — Humanetics Corp. presented data at the annual meetings of the American Society for Radiation ...

Optellum, a high-tech startup in lung cancer and machine learning, and Mirada Medical recently announced a partnership to accelerate the deployment of deep learning technology to market. This collaboration combines the deep technology and clinical expertise of Optellum with the software platforms and rapid development know-how of Mirada. They have partnered to address what they call a huge and growing problem in lung cancer diagnosis: the management of patients with indeterminate pulmonary nodules.

Philips showcased the company’s latest magnetic resonance (MR) imaging solutions at the Radiological Society of North America’s 2017 annual meeting, Nov. 26-Dec. 1 in Chicago. This includes their newest MR system, MR Prodiva 1.5T (which is still U.S. Food and Drug Administration [FDA] 510(k) pending) that provides enhanced clinical performance, workflow and patient experience. Philips also unveiled new solutions to drastically reduce exam times and elevate neuro-oncology.